Skip to main content

and
  1. No Access

    Article

    Improving the performance status in advanced non-small cell lung cancer patients with chemotherapy (ImPACt trial): a phase 2 study

    This phase II trial is designed to test whether the performance status (PS) of metastatic non-small cell lung cancer (mNSCLC) patients (pts) can improve with chemotherapy if their poor PS (Eastern Cooperative ...

    Neha Pathak, Rakesh Garg, Sachin Khurana in Journal of Cancer Research and Clinical On… (2023)

  2. No Access

    Article

    Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution

    Chronic myeloid leukemia (CML) management during pregnancy is challenging. In this retrospective study, hospital records of CML patients treated between 2000 and 2021 were screened to identify patients who tri...

    Chethan R, Prabhat Singh Malik, Ranjit Kumar Sahoo in Annals of Hematology (2023)

  3. Article

    Open Access

    Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel

    Peripheral neuropathy is a common dose-limiting side effect of paclitaxel. To date, there is no effective strategy to prevent paclitaxel-induced peripheral neuropathy. A recent small phase II study demonstrate...

    Praful Pandey, Akash Kumar, Deepam Pushpam, Sachin Khurana, Prabhat Singh Malik in Trials (2023)

  4. No Access

    Article

    Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women

    In this study, we evaluate the cost and outcomes of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) plus fulvestrant, fulvestrant alone, and conventional chemotherapy as the second-line therapy for hormone re...

    Nidhi Gupta, Dharna Gupta, Jyoti Dixit in Applied Health Economics and Health Policy (2022)

  5. No Access

    Article

    Poems syndrome: consolidation with autologous stem cell transplantation

    Annie K. Baa, Santosh K. Chellapuram, Atul Sharma in Bone Marrow Transplantation (2021)

  6. Article

    Open Access

    Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma

    We investigated the impact of renal impairment (RI) on the outcome in multiple myeloma (MM) patients following induction and autologous stem cell transplantation (ASCT). Among 349 patients who received a first...

    Lalit Kumar, Santosh Kumar Chellapuram, Ramavat Dev in Clinical Hematology International (2019)

  7. No Access

    Article

    Prognostic Relevance of T Regulatory Cells in Patients with Advanced-Stage Serous Carcinoma Ovary

    Despite improved treatment options, recurrence rates remain high in ovarian cancer. Tumor microenvironment, particularly T cells, plays an important role in its natural history. The present study was conducted...

    Saphalta Baghmar, Lalit Kumar, Lata Rani in Indian Journal of Gynecologic Oncology (2016)

  8. No Access

    Article

    Autologous hematopoietic stem cell transplantation—what determines the outcome: an experience from North India

    Limited information is available from develo** countries about complications, pattern of infections, and long-term outcome of patients following high-dose chemotherapy (HDCT) and autologous blood stem cell t...

    Lalit Kumar, Prabhat Singh Malik, Gaurav Prakash, Ram Prabu in Annals of Hematology (2011)